NEW YORK ( TheStreet) -- Shares of Neoprobe Corporation (AMEX: NEOP) were gapping up Thursday morning with an open price 13.7% higher than Wednesday's closing price. The stock closed at $2.27 Wednesday and opened today's trading at $2.58. The average volume for Neoprobe has been 1.6 million shares per day over the past 30 days. Neoprobe has a market cap of $246.2 million and is part of the health care sector and health services industry. Shares are up 10.2% year to date as of the close of trading on Wednesday. Neoprobe Corporation, a biomedical company, engages in the development and commercialization of surgical and diagnostic oncology products that enhance patient treatment by meeting the critical decision making needs of physicians in the United States and internationally. TheStreet Ratings rates Neoprobe as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Neoprobe Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
More from Markets
Snap Shares Decline After Q3 Results Beat Estimate, Outlook Lags
The loss was narrower than expected, but guidance for the fourth quarter may have caused the stock to fall.
Twitter Reports Earnings Thursday -- Here Are 3 Key Factors to Track
Here are two short-term trends and one long-term trend investors must understand about Twitter.
Boeing Head of Commercial Airplanes to Leave Amid 737 MAX Crisis
Boeing's McAllister is leaving the aerospace giant as the crisis around the grounded 737 MAX jetliner continues to grow.